α1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1)
Methoxamine (Mox) is a well-known α1-adrenoceptor agonist, clinically used as a longer-acting analogue of epinephrine. 1R,2S-Mox (NRL001) has been also undergoing clinical testing to increase the canal resting pressure in patients with bowel incontinence. Here we show, that Mox hydrochloride acts as...
Saved in:
| Main Authors: | Kohutova Aneta, Münzova Dita, Pešl Martin, Rotrekl Vladimir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2023-06-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2023-0012 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The regulatory role of APE1 in epithelial‐to‐mesenchymal transition and in determining EGFR‐TKI responsiveness in non‐small‐cell lung cancer
by: Xiao Yang, et al.
Published: (2018-09-01) -
Targeting APE1/Ref-1 to alleviate formalin-induced pain and spinal neuro-inflammation in rats: a promising therapeutic approach
by: Eman Elgendy, et al.
Published: (2025-07-01) -
Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
by: Mamta D Naidu, et al.
Published: (2011-01-01) -
Apurinic/apyrimidinic endonuclease 1 alleviates inflammation in fibroblast-like synoviocytes from patients with rheumatoid arthritis
by: Ha-Reum Lee, et al.
Published: (2024-08-01) -
Development of FRET-based cap-snatching endonuclease assay
by: Jeeva Subbiah, et al.
Published: (2025-05-01)